This study is in progress, not accepting new patients
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Summary
- Eligibility
- for people ages 6-17 (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT03451851
- Phase
- Phase 3 Psoriasis Research Study
- Study Type
- Interventional
- Participants
- About 120 people participating
- Last Updated